Similarly, in head and neck squamous cell carcinoma (HNSCC), PSMD14 decreased E2F1 ubiquitination and degradation, which improved AKT pathway activation and SOX2 transcription, thereby facilitating HNSCC growth, chemoresistance, and stemness [48]. The gene discussed is PSMD14; the disease is head and neck squamous cell carcinoma.